 |
|
|
|
|
 |
 |
 |
 |
|
 |
 |
|
||
 |
 |
 |
|
|
Questions and Answers Concerning Chronic Angina & EECP® Treatment
Click on a question
What
is angina?
What causes angina?
How does angina affect people?
How is angina avoided?
What is the first line of treatment for angina?
What if medication fails to control angina?
What is an angiogram?
What is angioplasty?
What is
augmentation?
What is blood pressure?
What is the cardiac cycle?
What is collateral circulation?
What are coronary arteries?
What is coronary artery bypass grafting (CAGB)
?
What is coronary atherosclerosis?
What is an electrocardiogram (ECG) ?
What is restenosis?
Does bypass surgery always work?
What are Thallium or Sestamibi scans?
What is systolic unloading?
What is EECP® treatment?
What does the name Enhanced External Counterpulsation
(EECP®) mean?
What are the advantages of EECP® treatment
over other treatments
for angina?
What happens during treatment?
Am I a candidate for EECP® treatment?
How does EECP® treatment work?
Are there downsides to the procedure?
What have studies of EECP® treatment shown?
Would I feel better after EECP® treatment?
What are the risks?
Does EECP® treatment eliminate the need for
surgery?
How often would I be treated?
How long has EECP® been used in the treatment
of angina?
Can EECP help heart failure patients?
Angina pectoris literally means "strangling in the chest." It is the most common symptom of coronary artery disease. The majority of patients with angina complain of chest discomfort provoked by mental, physical, or emotional stress. The discomfort can vary widely among patients who report shortness of breath, fatigue, indigestion, faintness, pain in the chess, arm neck or jaw and other symptoms.
Angina signals that a part of the heart muscle is not receiving an adequate supply of blood and oxygen. The heart requires a particularly rich blood supply because of its heavy workload and receives its nourishing blood supply thorough the coronary arteries. When narrowed or blocked arteries restrict blood flow, oxygen supply to portions of the heart may at times be insufficient. Increases in oxygen demand can occur during exercise, fever, rises in emotion, periods of hypoglycaemia, or after meals, triggering the onset of angina.
HOW DOES ANGINA AFFECT PEOPLE?
Angina often occurs when exertion outstrips the ability of narrowed or blocked coronary arteries to supply blood to the heart muscle. Angina restricts activities for many patients. They are able to walk, but not uphill or while carrying packages. For some, angina is disabling as it interferes with their ability to work or engage in almost any activity.
Doctors recommend controlling the risk factors that contribute to the underlying coronary artery disease. These risk factors include high blood pressure, diabetes, cigarette smoking, high blood cholesterol levels, and excess weight.
WHAT IS THE FIRST LINE OF TREATMENT FOR ANGINA?
Angina is usually controlled by one or more medications that either increase the supply of oxygen to the deprived heart muscle by dilating coronary vessels, or decrease the heart's demand for oxygen by slowing the heart rate, decreasing intensity of contraction or reducing stress within the walls of the hearts chambers. Unfortunately, in most patients, medication becomes insufficiently effective over time.
WHAT IF MEDICATION FAILS TO CONTROL ANGINA?
Bypass surgery or angioplasty is usually recommended if medication fails to ease angina or if the risk of heart attack is high. For some patients, EECP® treatment is another option that may relieve or eliminate angina by improving oxygen delivery to the heart muscle.
Angiograms are used to evaluate the condition of the coronary arteries and nourishment of the heart muscle. A dye which can be imaged by x-ray techniques is injected into the heart's blood vessels via a catheter, providing a recordable view of blood as it courses through the heart's arteries.
Percutaneous Transluminal Coronary Angioplasty (PTCA) is an invasive procedure that involves inserting a slim hollow tube through a major artery and into a blocked vessel. A small balloon at the tip of the catheter is inflated alongside the obstructing plaque deposits, flattening them against the vessel wall to restore blood flow. No anaesthesia is necessary. The patient often can go home the same day.
When the heart contracts during its pumping phase (systole), the coronary vasculature is squeezed by the powerful contraction of heart muscle, limiting the flow of blood to and within the muscle (myocardium). The myocardium must therefore receive most of its oxygenated blood during its period of relaxation (diastole), when large coronary arteries are most receptive to blood flow. Muscles, especially the large weight-bearing ones of the lower body, contain large numbers of blood vessels that cumulatively hold a large volume of blood. During EECP® treatment, at the onset of each diastole, compressive air cuffs that surround the muscles of the lower body are quickly inflated in rapid succession, first at the calves, then at the lower thighs, then at the upper thighs and buttocks. The rapid and precisely timed "squeezing" of the muscles sends a wave of blood (and pressure) that travels toward the heart through both veins and arteries. The sequential compression ensures that the waves generated in the more distant calf muscles can pass under the next cuffs (lower thighs) and be reinforced (not trapped) by the second and third compressions of the sequence. The result of the combined compressions is an increase in venous return (delivery of deoxygenated blood to the right atrium), and an "augmentation" or enhancement of diastolic pressure, which improves myocardial perfusion (flow of blood through the coronary arteries and to the heart muscle.
The amount of blood pumped out of the heart (cardiac output), the tone of the walls of the arteries (vascular resistance), and the volume and viscosity of the blood influence the pressure (expressed in millimetres of mercury) of the blood against the walls of the arteries. Each blood pressure measurement has two numbers. The first or top number is systolic blood pressure (pressure within the arteries during systole, when the heart is contracting). The second or bottom number is diastolic pressure (pressure within the arteries when the heart is relaxing). Normally, systolic pressure is the higher number. During EECP® treatment sessions, diastolic pressure is increased and systolic pressure is decreased, usually to a degree that diastolic pressure exceeds systolic pressure.
The cardiac cycle is the period from the beginning of one heartbeat to the beginning of the next. The cardiac cycle includes diastole when the heart relaxes and fills with blood, and systole when the heart contracts and pumps blood out of the body.
WHAT IS COLLATERAL CIRCULATION?
When a blockage (stenosis) within an artery prevents that vessel from delivering an adequate supply of blood to the tissues it serves, the body can sometimes compensate by developing and/or opening small specialised vessels to transfer blood form "healthier" arteries to the deprived tissues that are downstream of the blockage. The result of these special vascular networks that channel blood from one arterial branch to another is termed collateral circulation. The natural development of collaterals, however, is a gradual process, and heart patients often cannot produce them in the time or quantity necessary to relieve or reduce symptoms.
(A possible explanation for the long-term reduction in angina often associated with one course of EECP® treatment is that the procedure may improve the body's ability to develop collateral channels, which once established, tend to remain).
Enveloping the heart, these arteries provide the heart with its own nourishing supply of blood.
WHAT IS CORONARY ARTERY BYPASS GRAFTING (CABG)?
In traditional bypass operations, an incision is made along the midline of the chest through the breastbone. During part of the operation, heart and lung functions are assumed by a heart-lung machine. Blood vessels from another part of the body (usually the leg or chest wall)) are harvested or re-routed for grafting to diseased arteries to create conduits around blocked sections of the vessels.
WHAT IS CORONARY ATHEROSCLEROSIS?
Every year one million American develop atherosclerosis, partial or total blockage of arteries caused by deposits of fatty substances (plaques) in and on the walls of the vessels. The coronary arteries that supply blood to the heart are especially vulnerable.
WHAT IS AN ELECTROCARDIOGRAM (ECG)?
An electrocardiogram is a recording of the heart's electrical activity. It is detected by electrodes attached to the skin, and recorded in waves that are displayed graphically. The ECG provides information on heart rate, rhythm, and function. An ECG may also indicate the presence of heart damage or inadequate blood and oxygen supply to the heart muscle, and abnormalities of heart structure.
Unfortunately, treatment to clear blockages often results in cell re-growth that can obstruct vessels again. This condition called restenosis occurs after 20 to 30 percent of PTCA procedures. (The Merck Manual of Diagnosis and Therapy, Merck Research Laboratories, 1992). Repeat procedures are not uncommon and restenosis rates after repeat PTCA are as high as 50 percent. (Cath-Lab Digest, Jan/Feb, 1997).
DOES BYPASS SURGERY ALWAYS WORK?
For patients who have undergone CABG, repeat procedures are sometimes necessary. Six to ten percent of CABG procedures are now re-operations. However, re-operative mortality rates are two or three times those of the initial procedure and range from two to ten percent for second operations and up to fifteen percent for third and subsequent operations. Patients undergoing repeat procedures generally have more advanced coronary artery disease rendering the revascularisation process less effective. (Cath-Lab Digest, Jan/Feb, 1997).
WHAT ARE THALLIUM OR SESTAMIBI SCANS?
Coronary perfusion scanning is a nuclear imaging technique used to evaluate coronary blood flow. Agents containing tracers such thallium-201 or technetium-99m are injected into the blood stream. The material is carried through the coronary arteries and into the capillaries of the myocardium (heart muscle), where it can be absorbed by the myocardial cells. Energy given off by the tracers is detected and processed by special computerized camera systems. Images are produced that show how the tracers were distributed within the heart muscle. Tissues that are well supplied with blood absorb more tracers, and record as the light areas on scan images. Portions of the heart muscle receiving diminished supplies of blood record proportionately lower levels of tracers, and are imaged with correspondingly less intensity (darker, or black). By comparing scans made while a patient is physically stressed (by exercise or pharmacologicals) with those recorded following a period of rest, diagnostic information regarding the condition of specific portions of the myocardium can be obtained.
During EECP® treatment, the air cuffs are simultaneously and quickly deflated at the beginning of each systole (ventricular contraction), relieving the compressive force that was being maintained by the inflated cuffs, this decompression allows vessels that had been "squeezed" by the cuffs to quickly reconform, and reducing resistance to the pumping action of the heart. This "unloading" of resistance during the hearts contraction phase (systole) increases the hearts output (volume of blood ejected with each contraction). The heart's oxygen demand is actually lowered as a result of the improved pumping efficiency.
EECP® treatment is a non-invasive outpatient treatment that may relieve or eliminate angina.
WHAT DOES THE NAME ENHANCED EXTERNAL COUNTERPULSATION (EECP®) MEAN?
The term Enhanced External Counterpulsation (EECP®) describes what happens during treatment. EECP® treatment is "External" because it happens outside of the body and doesn't require surgery or other invasive procedures. "Enhanced" refers to the equipment that has evolved over decades of research and development to become the state-of-the-art treatment delivery system now used in EECP® treatment centres. Counterpulsation occurs between heart beats (the end of diastole). Counterpulsation increases blood flow to the heart muscle, decreases the heart's workload, and creates greater oxygen supply while lowering oxygen demand.
WHAT ARE THE ADVANTAGES OF EECP® THERAPY OVER OTHER TREATMENTS FOR ANGINA?
Unlike procedures
such as bypass surgery and balloon angioplasty, EECP® treatment
carries little or no risk and is relatively comfortable.
Some patients may require bypass surgery. Enhanced External Counterpulsation
is an option for patients' who are unsuitable for invasive procedures
or unwilling to undergo them. For patients who have undergone multiple
invasive procedures and for whom addition surgery carries excessive risk,
Enhanced External Counterpulsation may be the only way to obtain relief
form crippling angina.
WHAT HAPPENS DURING TREATMENT?
Patients lie on a padded table in a treatment room. Three electrodes are applied to the chest to record a constant ECG reading. A finger sensor, called a plethysmograph, records a tracing that represents blood pressure. A set of cuffs is wrapped around the calves, thighs and buttocks. The system uses an ECG signal to electronically synchronise inflation and deflation of the cuffs. Patients experience a sensation of a strong "hug" moving upwards from the calves to thighs to buttocks during inflation followed the rapid relief of pressure on deflation. During EECP®treatment, a display shows an ECG signal and a blood pressure tracing. An EECP®therapist uses these readings to time Counterpulsation and monitor treatment.
AM I A CANDIDATE FOR EECP® TREATMENT?
Ask your physician to evaluate you. You may be a candidate for EECP® if you:
- Have chronic stable angina.
- Are not receiving adequate relief from angina by taking nitrates.
- Do not qualify as a candidate for invasive procedures.
- Have exhausted invasive treatments without lasting relief of symptoms.
- Are unwilling to undergo surgery or angioplasty.
- Want to explore alternatives to bypass surgery or angioplasty.
HOW DOES EECP® TREATMENT WORK?
Normal heart
function depends on maintaining a balance between oxygen supply and demand.
Oxygen consumption by the cardiac muscle is determined by how fast your
heart is beating and how well it pumps. The amount of oxygen available
is determined by blood flow. Approximately 80 percent of the blood flow
to the cardiac muscle tissue occurs when the heart is resting.
Clinical studies indicate that EECP® treatment may create
a "natural" bypass of blocked arteries. EECP®
treatment encourages blood vessels to open or form small channels that
become extra branches. These channels, or collaterals, may eventually
become permanent pathways to the heart muscle that was previously deprived
of blood flow and adequate oxygen.
ARE THERE DOWNSIDES TO THE PROCEDURE?
The length of treatment may be a consideration for some people. It can take between four and seven weeks to complete a course of EECP® treatment. During that time, patients must visit an outpatient clinic and receive treatment for one to two hours per day. Some patients may require more than one course of therapy to achieve an optimal level of relief.
WHAT HAVE STUDIES SHOWN ABOUT EECP® TREATMENT?
Clinical studies have shown that EECP® is an effective treatment for angina. A randomised, controlled, blind study showed a significant increase in the length of time that participants who received active treatment were able to exercise. Additionally, participants who received active treatment experienced fewer episodes of angina. Studies have demonstrated benefits including:
- Elimination or decrease in exercise-induced signs of lack of oxygen to the heart muscle (ischaemia).
- Increased exercise tolerance
- Elimination or decrease in episodes of angina
- Decrease in need for anti-anginal medication
WOULD I FEEL BETTER AFTER HAVING EECP® TREATMENT?
- Patients can walk further, carry heavier packages, and be more active without having angina.
- Patients have fewer episodes of angina.
- Episodes of angina are less painful.
- Patients need less anti-anginal medication.
- Patients can return to work, go out to dinner, garden, travel or enjoy golf, tennis, or bowling once again.
- Patients feel more confident about participating in their social lives, volunteer activities, and exercise without interference from angina
Some patients have experienced minor skin irritation due to the pressure of the cuffs. You should consult with your physician regarding any risk and complication factors.
DOES EECP® THERAPY ELIMINATE THE NEED FOR BYPASS SURGERY?
Unlike procedures
such as bypass surgery and balloon angioplasty, EECP® treatment
is administered in outpatient sessions, carries little or no risk, and
is relatively comfortable.
Some patients with more extensive disease or who have disease of the left
main coronary artery may require bypass surgery. EECP®
treatment is an option for patients who are unsuitable for invasive procedures
or unwilling to undergo them. For patients who have undergone multiple
invasive procedures and for whom additional surgery carries excessive
risk, EECP® therapy may be the only way to obtain relief
from crippling angina.
Patients
typically attend one-hour treatment sessions once a day, five days a week,
for seven weeks. Many people have continued their employment while receiving
treatment by scheduling their sessions before or after work.
Patients with extensive atherosclerotic disease may require more than
35 hours of treatment to achieve optimal benefit.
HOW LONG HAS EECP® BEEN USED TO TREAT ANGINA?
In 1989, researchers at State University of New York at Stony Brook began clinical studies of EECP® treatment. Until the summer of 1995, EECP® therapy was only available to patients participating in clinical studies. Today, EECP® therapy is available at treatment centres throughout the world.
CAN EECP HELP HEART FAILURE PATIENTS?
A recent study “The prospective
evaluation of EECP in Heart Failure (PEECH) Trial” showed that EECP
can benefit patients with stable heart failure (HF) and Left Ventricular
Dysfunction (LVD).
If there are any questions you have that have not been answered then please contact us on (01274) 201 689.
Vasogenics
(U.K) Ltd,
P.O Box 71, Bradford, West Yorkshire BD14 6UL
Telephone
44 (0)1274 201689
Home About EECP® EECP Centres® Links Angina Case studies Testimonials Contact us
EECP®
is a registered trademark of Vasomedical, Inc., Westbury, New York
Vasogenics is an Authorised Distributor for Vasomedical Inc